Furthermore, we demonstrate that (i) subsets of cells characterized by high levels of coexpressed α6 integrin and E-cadherin are enriched during the progression from primary tumour to hepatic metastasis in animal models, and (ii) patients whose primary adenocarcinomas express high amounts of this receptor exhibit a shorter disease-free survival. This evidence concerns the gene CDH1 and adenocarcinoma.